Subscribe
shutterstock_1017347380_sundryphotography
sundryphotography / Shutterstock.com
18 February 2019Americas

J&J to buy surgical robotics company for $3.4bn

Johnson & Johnson (J&J) has  announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Johnson & Johnson braces for Q3 sales dip as generics bite
18 July 2019   Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.
Americas
J&J to acquire Verily stake in Verb Surgical
23 December 2019   Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.
Americas
Surgical device maker hit with $10m damages in stapler patent dispute
20 October 2022   Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Surgical device maker hit with $10m damages in stapler patent dispute
20 October 2022   Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.
Big Pharma
Johnson & Johnson braces for Q3 sales dip as generics bite
18 July 2019   Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.
Americas
J&J to acquire Verily stake in Verb Surgical
23 December 2019   Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

More on this story

Americas
Surgical device maker hit with $10m damages in stapler patent dispute
20 October 2022   Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.
Big Pharma
Johnson & Johnson braces for Q3 sales dip as generics bite
18 July 2019   Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.
Americas
J&J to acquire Verily stake in Verb Surgical
23 December 2019   Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

More features

GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks
Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch